Severity of hair loss and quality of life for patients with central centrifugal cicatricial alopecia

Documenti analoghi

• Patch test positive results in patients with biopsy‐proven central centrifugal cicatricial alopecia
  di: Rami H. Mahmoud, et al.
  Pubblicazione: (2024)
• Long‐term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO‐LT phase 3, open‐label study
  di: C. Tziotzios, et al.
  Pubblicazione: (2025)
• Real‐life effectiveness and safety of baricitinib in patients with severe alopecia areata: A 24‐week Italian study
  di: B. M. Piraccini, et al.
  Pubblicazione: (2024)
• Real‐life effectiveness and safety of baricitinib in adults with alopecia areata: A multicentre study
  di: A. Mourtada, et al.
  Pubblicazione: (2025)
• Correction to ‘Long‐term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO‐LT phase 3, open‐label study’
  Pubblicazione: (2025)